Aaron I. Davis, Director at Rain Therapeutics Inc. (RAIN), bought 1,944,424 shares at $5.83 ($11.3M) on 2022-11-04, disclosed to the SEC on 2022-11-08.
Open-market purchase of $11.3M RAIN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.83 | 972,212 | $5.7M | 50.0% |
| 2 | $5.83 | 972,212 | $5.7M | 50.0% |
| Total | $5.83 avg | 1,944,424 | $11.3M | 100% |
| Filing → |
| TYRA | SELL | 2023-02-13 | $4.4M | — | Filing → |
| ITOS | SELL | 2022-05-11 | $20.2M | — | Filing → |
| ITOS | SELL | 2022-05-02 | $10.2M | — | Filing → |